$BX RESULTS: Q3 🔸 Distributable income/share $1.01 vs. $0.94 y/y, EST $0.91 🔸 Assets under management $1.11 trillion, +10% y/y, EST $1.1 trillion 🔸 Real estate assets under management $325.08B, -1.9% y/y, EST $341.06B 🔸 Private equity assets under management $344.71B, +12% y/y, EST $337.25B 🔸 Credit and insurance assets under management $354.74B, +22% y/y, EST $341.01B 🔸 Total segment revenue $2.43B, +4.8% y/y, EST $2.36B 🔸 Fee-related earnings $1.18B, +4.5% y/y, EST $1.15B 🔸 Fee-related earnings per share $0.96 vs. $0.92 y/y, EST $0.94 🔸 Inflows $40.54B, EST $35.8B 🔸 Outflows $11.32B, 🔸 Total dry powder $171.6B 🔸 Realizations $22.7B 🔸 Deployment $34.0B, EST $25.81B 🔸 Net realizations $225.5M, -13% y/y

#Downgrades - Oct 09, 2024 $ARCB: Wolfe Research Downgrades to Peer Perform from Outperform $BX: Piper Sandler Downgrades to Neutral from Overweight - PT $149 $CIEN: BNP Paribas Downgrades to Neutral from Outperform - PT $67 $CMC: Wolfe Research Downgrades to Peerperform from Outperform $DQ: HSBC Downgrades to Hold from Buy - PT $25 $EXPD: Wolfe Research Downgrades to Underperform from Peer Perform - PT $111 $FDS: Redburn-Atlantic Downgrades to Sell from Neutral - PT $380 (from $420) $LVS: CFRA Downgrades to Hold from Buy - PT $51 (from $55) $MORN: Redburn-Atlantic Downgrades to Neutral from Buy - PT $340 $VALE: Wolfe Research Downgrades to Underperform from Peer Perform $XOM: BNP Paribas Downgrades to Underperform from Neutral - PT $105

#Downgrades - Sep 19, 2024 $ATHA: Mizuho Downgrades to Neutral from Outperform - PT $0.50 (from $5) $BX: CFRA Downgrades to Sell from Hold - PT $140 (from $107) $CASY: JPMorgan Downgrades to Underweight from Neutral - PT $337 (from $300) $ELAN: Morgan Stanley Downgrades to Equalweight from Overweight - PT $15 (from $17) $FIVE: JPMorgan Downgrades to Underweight from Neutral - PT $95 (from $89) $HALO: JPMorgan Downgrades to Neutral from Overweight - PT $57 (from $52) $LFT: Raymond James Downgrades to Market Perform from Outperform $MUSA: JPMorgan Downgrades to Underweight from Neutral - PT $435 (from $415) $NREF: Raymond James Downgrades to Market Perform from Strong Buy $PGNY: JMP Securities Downgrades to Market Perform from Market Outperform $VSTO: Roth/MKM Downgrades to Neutral from Buy - PT $42 $WSC: Barclays Downgrades to Equalweight from Overweight - PT $44 (from $50) $